Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin

NCT00384215 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: insulin glargine [rDNA origin] injection

Sponsor

Sanofi